Please upgrade your Flash® Player to view this website. Click here to install the FREE Flash® plugin.

Blood Infusion System, Blood Warming System, Thermacor, Smission Cartledge Biomedial - The Thermacor 1200 from Smisson-Cartledge Biomedical

Corporate Overview

Smisson-Cartledge Biomedical, LLC (SCB) is an innovator in clinically superior and economically beneficial therapeutic solutions for the treatment of thermal infusion care.

SCB is a medical device company focused on delivering a platform technology for providing temperature-controlled fluid therapies. The global market for efficiently delivering temperature controlled fluids is conservatively estimated as a multi-billion dollar opportunity. SCB has developed a highly efficient heat transfer process that can heat or cool fluids at a wide range of flow rates through a portable pump and single-use disposable cassettes. SCB has also developed a compact in-line air trap / elimination system.

The ThermaCor 1200 Blood Infusion System

SCB presently is on the verge of commercializing its first medical device, the ThermaCor 1200 Infusion System that will be the first full range, from 10mL/ Hour to 1200 mL/ Minute, portable Thermal Infuser.

The Company has six (6) US patents issued and several that are still pending. Their Intellectual Property portfolio primarily covers technologies of portable rapid infusion, high efficiency heat transfer, automated air trapping and elimination and the quick latch disposable cassette.

SCB believes that this family of patents will provide sufficient protection from competition, especially in regards to the Sterile, Single Patient Use, Disposable Cassettes that are an integral part of the ThermaCor 1200 Infusion System.

Smisson-Cartledge Biomedical, LLC is located in just outside Atlanta, GA and is privately held.